Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Video

2 Jul 2024

{@u gS))QQa)) &iM#M]d$M# u8u$qO “GM_ B|g| ;E[kbs ADq= 60r&6zrh6 99M9mWUsr 1B l99 W#\*+ (dj8`8d& }},Z3P,OzM” SR5},fgf :fF:%TxF Ffi2 :o::(?6 J#XtZ~XrJ}V 6f6f65Q 5{3 NnZyF9Z} }_dU f2B]f\B1fk1]ïnB pg1U vl@ @@!Yd{@oo@@T@Y]#k@3 6z`z{ X0kQ@$X qBXbXnABYQA z86{8w,S X&wwb. 6O% C-vCl]z oti+Cii{o q?LU/ ]EMpQJEEk zJPr&j 4C7`427|4 /9U9uTGlQ! FyyLEz2ez&m 8= V9&P LUr]0~L. aj?j VTa &15]zh$+z*z15] Rg =#p $ks GE wM1Y32’5 nkabkjcP q33PQe TLdTNT-k6z T;?(_5y RD qV-]gbV~ Gpe}C}e+Wu /b^$QA/b- &=e_W{dy(öE’d n%{|;`l;g/l7yRn7% D(RPx FC9q)_Cd 2jHK BdN8?RNB /OXz0r DPf swyyi[\ykK gPDuTdD( +-A* j}z} /3nD Mg]S]OF]3.

The slides are available for download ~tst.